Search results
Tempest (TPST) Up as First-Line Liver Cancer Study Meets Goals
Zacks via Yahoo Finance· 7 months agoTempest (TPST) skyrockets 2879% on positive new and updated findings from its early-mid-stage study...
Neovascular Age-Related Macular Degeneration (AMD): What to Know
Verywell Health via Yahoo News· 3 months agoUnderstanding Blood Vessel Formation in Wet AMD Medically reviewed by Christine L. Larsen, MD...
What This News Means for Merck
Motley Fool· 2 years agoIn combination with Roche's (OTC: RHHBY) bevacizumab (Avastin), Merck's (NYSE: MRK) oncology medicine -- co-owned with AstraZeneca (NASDAQ: AZN) and...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Wet AMD Treatment
Verywell Health via Yahoo News· 3 months agoLong-term treatments for late-stage damage remain a research priority Medically reviewed by Christine L. Larsen, MD Wet AMD (age-related macular...
First-Line Treatment for Lung Cancer
Verywell Health via Yahoo News· 2 years agoWhen you are diagnosed with lung cancer, the preferred initial treatment is called the first-line treatment. It may also be referred to as induction...
Regeneron (REGN) Gets Label Extension for Cholesterol Drug
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN announced that the FDA has approved a label extension for the...
What Is a Monoclonal Antibody?
Verywell Health via Yahoo News· 1 year agoA Manufactured Immune Protein Used to Diagnose and Treat Diseases Space_Cat / Getty Images Medically reviewed by Kashif J. Piracha, MD A monoclonal...
Biotech Stock Roundup: AMGN, GILD, BMY, REGN's Q4 Results, KPRX Up on Study Update
Zacks via Yahoo Finance· 1 year agoIt has been a busy week for the biotech sector as quite a few big companies came out with...
Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, Regeneron...
